Zurich, Switzerland

HIRSLANDEN

INVESTOR DAY PRESENTATION 18 FEBRUARY 2015

WELCOME & INTRODUCTION

DANIE MEINTJES CEO MEDICLINIC INTERNATIONAL TIME LINE AND FINANCIAL OVERVIEW

CRAIG TINGLE CFO MEDICLINIC INTERNATIONAL HIRSLANDEN TIME LINE

1990 2005 Merger of 5 clinics to form 1997 – 2002 2002 Takeover of Klinik St. Anna HIRSLANDEN Takeover of 7 clinics Takeover by BC Partners Introduction of Tarmed

2007 2010 2007 2007 Mediclinic International Acquisition of Klinik New management team at Opening of Garden Wing at acquires Hirslanden’s 13 Stephanshorn Hirslanden Klinik Hirslanden hospitals

2013 2012 2012 2012 Enzenbühltrakt project Successful listing of 13 Major debt refinancing of completed at Klinik KVG revision and hospitals on cantonal CHF2.9 billion successfully Hirslanden introduction of DRGs hospital lists completed Opening of outpatient clinic at Bern Station

2014 2014 2015 2014 ABO funding Commissioning of First bond issues totalling Opening of outpatient Acquisition of Clinique La Männedorf radiotherapy CHF200 million clinic in Belair “Urbahn” Colline and Swissana unit Clinic

Hirslanden Analyst Presentation | February 2015 5 HIRSLANDEN KEY FINANCIAL INDICATORS

Revenue and EBITDA CAGR = 6.2% 1 500

CAGR = 5.1% 1 200

900

CHF‘m 600 CHF 299 CHF 286 CHF 285 CHF 278 CHF 266 CHF 245 300 CHF 222 CHF 1 001 CHF 1 091 CHF 1 134 CHF 1 218 CHF 1 270 CHF 1 330 CHF 1 436 0 FY2008 FY2009 FY2010 FY2011 FY2012 FY2013 FY2014

Revenue EBITDA

• Steady revenue and EBITDA growth • Normalised EBITDA shown • Major structural changes since early 2012 with listing, increase in generally insured patients and major long-term projects such as Lighthouse

Hirslanden Analyst Presentation | February 2015 6 HIRSLANDEN GEARING

Net debt : EBITDA

2,5 12,0 10,6 9,5

2,0 10,0 8,8 8,2 8,5 1,5 8,0 CHF’bn) 6,7 6,1 1,0 6,0 Net debt ( 0,5 4,0 CHF 2,34 CHF 2,34 CHF 2,33 CHF 2,34 CHF 2,37 CHF 1,91 CHF 1,83 0,0 2,0 FY2008 FY2009 FY2010 FY2011 FY2012 FY2013 FY2014

Net debt Net debt: EBITDA

• Declining net debt to EBITDA ratio • Positive effect of debt refinancing in October 2012 clearly seen from FY2013 onward • After refinancing, average interest rate decreased from 5.62% to 2.3% • CHF 180 m amortised on senior loan as at 30 September 2014 Hirslanden Analyst Presentation | February 2015 7 HIRSLANDEN INAUGURAL DUAL TRANCHE BOND ISSUE

• On 29 January 2015 Hirslanden accessed the CHF bond market • CHF 120 million at 1.625 % over 6 years, in combination with a CHF 80 million at 2.00 % with 10 year maturity • Final closing next week and further volume is possible • Aim of offering to refinance existing debt and diversify funding sources • Currently further refinancing options being evaluated • Rating of Baa- stable by Fedafin and Mid BB stable by Credit Suisse • Total transaction size the largest CHF new issue volume by a domestic health care sector issuer

Hirslanden Analyst Presentation | February 2015 8 OPERATIONAL OVERVIEW

OLE WIESINGER CEO HIRSLANDEN KEY FACTS SWITZERLAND

Hirslanden Analyst Presentation | February 2015 10 KEY FACTS SWITZERLAND

Official languages: Capital: Area: Government:

German None 41,285 km² Federal Multi- French party directorial 133rd Italian (Berne) republic Romansh

Population: GDP (PPP): Human GDP development (per capita): 8 million $ 385.333 index (HDI): Billion 0.917 $ 47,863 37th 3rd 8th

Hirslanden Analyst Presentation | February 2015 11 KEY FACTS LIFE EXPECTANCY AT BIRTH 1970 AND 2011 (OR NEAREST YEAR)

0 Switzerland Germany OECD USA UAE India South Africa

Data: OECD Health Statistics 2013. | Source UAE: indexmundi. United Arab Emirates - Life expectancy at birth

Hirslanden Analyst Presentation | February 2015 12 KEY FACTS HEALTH EXPENDITURE PER CAPITA IN USD, 2011 (OR NEAREST YEAR)

9000

8000

7000

6000

5000

4000

3000

2000

1000

0 Switzerland Germany OECD USA UAE India South Africa

Data: OECD Health Statistics 2013. | Source UAE: The World Bank - Health expenditure per capita

Hirslanden Analyst Presentation | February 2015 13 ENVIRONMENTAL CHALLENGES

Hirslanden Analyst Presentation | February 2015 14 ENVIRONMENTAL CHALLENGES

Outmigration of care Decreasing turnover per case Aging society

From acute to chronical Regulatory environment Human resources

Power of networks Increased transparency Limited market access

Hirslanden Analyst Presentation | February 2015 15 REGULATORY ENVIRONMENT SWISS POLITICAL SYSTEM

• Multi-party federal directorial democratic republic • Federal Council of Switzerland as head of government and executive power • Legislative power exercised by government and two chambers: Council of State and National Council • Direct representation • Healthcare: Steered by cantonal governments

Hirslanden Analyst Presentation | February 2015 16 REGULATORY ENVIRONMENT SWISS FEDERAL STRUCTURE

Hirslanden Analyst Presentation | February 2015 17 REGULATORY ENVIRONMENT THE CANTONS’ MULTIPLES ROLES

Finance HSM Moratorium planning payer

Tariff Healthcare Hospital determina- regulator operator tion

Hirslanden Analyst Presentation | February 2015 18 HSM PLANNING THE APPROACH

«Conference of Highly Specialized Medicine» (assigned by the 26 Health Ministers), organised by cantons Purpose: Centralisation of Highly Specialized Medicine in Switzerland

Motivation criteria: • Small case load • Innovation potential • Need for specialized teams • Need for specialized infrastructures • Complexity of treatments • High costs

Hirslanden Analyst Presentation | February 2015 19

HSM PLANNING THE CHALLENGE

• Definition of HSM: What and who? • Distinction between specialised and highly-specialised medicine • Composition of decision making-body: Only representatives of public hospitals with multiple roles

Hirslanden Analyst Presentation | February 2015 20 REGULATORY ENVIRONMENT THE CANTONS’ MULTIPLES ROLES

Finance HSM Moratorium planning payer

Tariff Healthcare Hospital determina- regulator operator tion

Hirslanden Analyst Presentation | February 2015 21 HEALTHCARE REGULATOR HOSPITAL LIST - THE APPROACH

• Cantonal hospital lists • Goal of list: Cover all medical services required by the inhabitants of canton • Billing of treatment costs to patient’s canton of residence and basic insurance (50:50) by listed hospitals • Listing made by cantonal government • Mandate dictates offered medical services, obligations and requirements to be met (most important: Quality and economic efficiency, patients access to treatment, within a reasonable time)

Hirslanden Analyst Presentation | February 2015 22 HEALTHCARE REGULATOR HOSPITAL LIST – THE CHALLENGE

• Public service mandates for 15 out of 16 Hirslanden hospitals: Klinik Im Park’s objection (Canton of Zurich) rejected; reapplication for 2016 • Extensive service mandates • Ongoing court cases (BE, SG)

Hirslanden Analyst Presentation | February 2015 23 HEALTHCARE REGULATOR FURTHER REGULATORY CHALLENGES

• Provisional DRG base rates • Outpatient tariff adjustment (shift of 200m Swiss francs from specialists to basic service providers) • Canton Vaud: Cantonal influence in acquisition of large medical equipment

Hirslanden Analyst Presentation | February 2015 24 ENVIRONMENTAL CHALLENGES

Outmigration of care Decreasing turnover per case Aging society

From acute to chronical Regulatory environment Human resources

Power of networks Increased transparency Limited market access

Hirslanden Analyst Presentation | February 2015 25 OUTMIGRATION OF CARE AMBULATORY SURGERY VISITS UNITED STATES 1996 AND 2006 Ambulatory Inpatient 90

0 1996 2006 Data: CDC/NCHS, National Survey of Ambulatory Surgery, 2006 and National Hospital Discharge Survey. Hirslanden Analyst Presentation | February 2015 26 OUTMIGRATION OF CARE DEVELOPMENT IN OUTPATIENT BUSINESS IN SWITZERLAND

Proportion of in- and outpatient cases in Swiss Hospitals 1996, 2004 and 2012 100 90 80 70 60 50 Outpatient 40 Inpatient 30 20 10 0 1996 2004 2012

Data: The Swiss Hospital Association H+, May 2014 Hirslanden Analyst Presentation | February 2015 27 BUSINESS OVERVIEW AND KEY STATISTICS

Hirslanden Analyst Presentation | February 2015 28 THE SWISS HOSPITAL MARKET

General Hospitals Employees (FTE) Beds 175 Hospitals 123'269 FTE 23'852 Acute beds 16% of privately held 32% of privately held 8% of total 35% of privately held 4% of total 6% of total 18%

82%

Patient Care Days Cases Hirslanden Explanation 8.3m days 1.1m treated patients -Hirslanden's market share in % of private hospitals 31% of privately held 38% of privately held -Hirslanden's overall m/s 5% of total 7% of total 15% 18% Private Hospitals 85% 82%

Public Hospitals

Data: Swiss Federal Statistical Office (2012); Hirslanden. Hirslanden Analyst Presentation | February 2015 29 HIRSLANDEN OUR HOSPITALS

Hirslanden Analyst Presentation | February 2015 30 HIRSLANDEN OUR AFFILIATED DOCTORS

Hirslanden Analyst Presentation | February 2015 31 HIRSLANDEN OUR REFERRING DOCTORS

Hirslanden Analyst Presentation | February 2015 32 OPERATIONAL OVERVIEW

HOSPITALS BEDS 16 1 650

EMPLOYED VISITING EMPLOYEES SPECIALISTS SPECIALISTS 235 1 493 6 246

Hirslanden Analyst Presentation | February 2015 33 100 000 100 20 000 20 000 40 000 60 000 80 1 000 2 000 3 000 4 000 5 000 6 000 7 000 GROWTH AT GROWTH 0 Hirslanden 0 CAGR: 2006 2004 CAGR: 4.4% 3 607 29 016 3 628 56 719 2005 5.4% 2007 29 245 3 776

66 315 3 860 2006 Patients

08/09 34 062 4 107 67 019 4 166 2007 35 409

09/10 69 642 ( inpatient

4 288 08/09 4 343

FTE FTE 35 178 73 448 10/11 09/10 HIRSLANDEN

4 419

34 553 cases) 4 576 73 582 10/11 11/12 4 786 35 551 4 871 77 643 11/12

12/13 37 808 5 016 80 588 Analyst PresentationFebruaryAnalyst 2015 |

5 065 12/13 38 898 13/14 82 669 5 298 13/14

5 530 13.8% 41 006 6.5%

14/15 87 248 14/15

6 031 43 660 600 000 600 100 000 100 000 200 000 300 000 400 000 500 4,00 4,20 4,40 4,60 4,80 5,00 5,20 5,40 0 2004 2004 CAGR: CAGR: CAGR: 177 056 5,15 347 754 5,13 2005 2005 6.8% - % % 3.8

0.7% 176 134 5,03 394 988 5,13

2006

205 795 5,05 404 990 5,07 Average 2007 2007 212 299 5,00 4,98

416 988 Patient 08/09 08/09 4,94 208 830 length 433 737 4,90 09/10 09/10 205 790 days 4,96

435 240 4,91 of 10/11 10/11

211 681 4,95 stay 459 638 4,92

11/12 11/12 221 635 4,87 468 946 4,82 12/13 12/13 225 985 4,81 479 157 4,80 13/14 13/14 239 540 4,84 % 0.5 + % 7.0 34 505 959 4,80 8.3% 14/15 14/15

256 209 4,87

BUSINESS PERFORMANCE

YEAR-ON-YEAR INPATIENT GROWTH HY2014 – HY2015

• CHF 56 million Revenue growth Basic + 11.3%

- 6.6% increase in inpatients Semiprivate + 2.3% - 2.7% increase in average Private + 4.1%

revenue per case Total + 6.6%

• Stable average length of stay at 4.9 days

• 134% of normalised EBITDA converted into cash generated from operations

Hirslanden Analyst Presentation | February 2015 BED OCCUPANCY AND DEVELOPMENT

• Beds increased from 1 567 to 1 650 during the reporting period • Bed occupancy is in line with HY2014 (72.2%) and still constantly above 70%

* Defined as midnight census divided by number of beds times days in reporting period Note: Average bed occupancy rates for full years generally higher than first-half year occupancy rates, mainly due to higher occupancies over the winter period from November to March

Hirslanden Analyst Presentation | February 2015 36 BUSINESS PERFORMANCE

• Continued growth supported by two acquisitions: Clinique La Colline in Geneva and Swissana Clinic in Meggen • Solid performance and stable financials • Normalised EBITDA margin declined as expected due to: - increase in generally insured patients - investment for the future (Lighthouse and Zenlop)

Hirslanden Analyst Presentation | February 2015 37 OUR HISTORY ACQUISITION: CLINIQUE LA COLLINE ACQUISITION: HIRSLANDEN KLINIK MEGGEN OUTPATIENT CENTER: PRAXISZENTRUM AM BAHNHOF OUTPATIENT CENTER: PRAXISZENTRUM AM BAHNHOF SCHAFFHAUSEN RADIOTHERAPY MÄNNEDORF BUILDING AND MEDTECH PROJECTS

COMPLETED DURING LAST SIX MONTHS

BUILDING COMPLETED BEDS Clinique La Colline (Emergency unit, doctors Jun 2014 - practice) Clinique Bois-Cerf (Daycare) Aug 2014 7 Andreas Klinik Cham Zug (Doctors’ practices) Sep 2014 - Totals 7

Clinique La Colline Emergency Unit

MEDTECH COMPLETED Klinik Im Park, Schanze (CT 64 and Aug 2014 mammography) Clinique Cecil (Catheter lab – biplane) Jun 2014 Radiotherapy Männedorf (LINAC) Mar 2014 Klinik St. Anna (PET CT) Sep 2014

Radiotherapy Hirslanden Männedorf (Linac) Hirslanden Analyst Presentation | February 2015 43 BUILDING AND MEDTECH PROJECTS

COMPLETE DURING THE NEXT SIX MONTHS

EXPECTED BUILDING COMPLETION BEDS Klinik Belair (Outpatient clinic Oct 2014 - “Urbahn”) Klinik Hirslanden (Entrance and back Oct 2014 - office area) Salem-Spital (Entrance, pharmacy) Dec 2014 - Klinik Im Park (Hybrid operating Dec 2014 - theatre) Klinik Stephanshorn Emergency room Klinik St. Anna (Doctors’ practices) Mar 2015 - Klinik Stephanshorn (Bed wing, Mar 2015 24 emergency room) Hirslanden Klinik Aarau (New ward April 2015 10 for privately insured patients) Klinik Birshof Phase 2: Practices, emergency room May 2015 - Phase 3: Radiology unit

Hirslanden Analyst Presentation | February 2015 44 BUILDING AND MEDTECH PROJECTS

COMPLETE DURING THE NEXT SIX MONTHS

EXPECTED MEDTECH COMPLETION Klinik Beau-Site (MRI 3T) Oct 2014 Klinik Im Park (Hybrid - angiography) Dec 2014 Klinik St. Anna (Angiography) Dec 2014 Klinik St. Anna (Da Vinci / urology) Mar 2015

Klinik Im Park Hybrid - Angiography

Hirslanden Analyst Presentation | February 2015 45 HIRSLANDEN PRIVÉ

• Free choice of doctor and hospital • Fast access to desired medical treatment • Privacy in a single room • A wide range of hospitality services and an individual care programme • Hirslanden Privé Membership

Hirslanden Analyst Presentation | February 2015 46 CURRENT PROJECTS

Hirslanden Analyst Presentation | February 2015 47 HLT – HIRSLANDEN HOSPITAL INFORMATION SYSTEM

• Standardised administrative and medical processes • Optimisation of treatment quality • Group-wide introduction until 2018

Hirslanden Analyst Presentation | February 2015 48 ZENLOP CENTRAL LOGISTICS PLATFORM

• Central logistics platform for expendable materials • Cooperation with Swiss Post • Since December 2014: Supply of 10 Hirslanden Hospitals • Economies of scale in buying • Streamlined range of materials

Hirslanden Analyst Presentation | February 2015 49 THANK YOU

Hirslanden Analyst Presentation | February 2015 50 © Daniel Liedtke, Klinik Hirslanden 1 AGENDA

• A brief history of Klinik Hirslanden • Who are our health consumers? • Which promises do we offer to our patients? • How do we manage our processes? • How do we achieve value? • Our vision • Take home message

3 TRADITION AND INNOVATION SINCE 1932 • Hospital list ZH

• Highly specialized medicine

• Garden wing opening • PET/CT scan • Klinik Hirslanden opening • Gastroenterology • Top chef Albert Hubmann • Intra-operative MRI from Parkhotel Weggis • Musculoskeletal • Lung & Thoracic • Opening Enzenbühl • Hirslanden Baby • Gynaecology Wing • Spine surgery • Radiotherapy • Introduction of • Restaurant Quadro • Vascular surgery promary nursing Hybrid-OR • Cardiology • Neuro Suite • Extension intensive care • Radiology

1932 1987 1997 1998 1999 2005 2007 2008 2009 2010 2011 2012 2013 2014

• CyberKnife • Emergency • Comprehensive • Refurbishment entrance • Da Vinci medicine Stroke area Robot Center • Urology • Head (and neck) • Acute Care Unit • Reference center • Oncology • Intra-operative CT bariatrics

• 1’600 employees • 415 affiliated and salaried doctors • 100 in-house physicians • 330 beds • 16’800 admissions/year • 107’800 patient days/year • 14 operating rooms • 24 intensive care beds

• 73% of our patients live within the canton of Zurich • 22% of our patients come from the rest of Switzerland • The remaining 5% are international patients

Patient mix overall: Patient mix by medical category:

10% Highly-specialised medicine: 90% specialised medicine: → thereof general-insured patients: 40 % → thereof general-insured patients: 15%

General = waiting time Private = no waiting time

versus

Depending on the capacitiy, access for No waiting time elective serious cases to highly-specialised doctors

general private

versus

Treatments by medical fellows & Treatments by residents supported by highly-specialised and very highly-specialised medical Teams experienced medical teams

Datum: 16.02.2015 © Daniel Liedtke, Klinik Hirslanden 11 INFRASTRUCTURE

general private

versus

Swiss Standard Infrastructure Excellent 4**** Infrastructure

Datum: 16.02.2015 © Daniel Liedtke, Klinik Hirslanden 12 SERVICE STANDARD

general private

versus

Swiss Standard Hospitality Excellent 4**** Hospitality

no difference between insurance categories

High-end medical technology 365 x 24h fast access for emergency cases

Datum: 16.02.2015 © Daniel Liedtke, Klinik Hirslanden 14 HOW DO WE MANAGE OUR PROCESSES?

Volume, Specialisation, Promises & Actual Services Indications Board, Team & for Patients and Doctors Guidelines

Patient Value & Medical Outcome + Trust / Satisfaction Hospital = Costs per case Performance

Standardisation & Productivity

© Daniel Liedtke, Klinik Hirslanden 17 REVENUE MODEL QUALITY AND COST LEADERSHIP The revenue model needs a hybrid strategy: A hospital will generate patient value if - with an increase of case volume - it succeeds in lowering costs and improving outcome and patient satisfaction at the same time.

Optimal Case Volume Patient Satisfaction

Medical Results

Economical Efficiency

Case Volume per medical condition Literatur: Fitzgerald, Moore, Dittus, (1988); Selbmann, (2003); Coeffey, Louis, (2000); Liedtke (2010)

2012 2013 2014

Beds (at 31.03.XX) 259 259 330 Inpatients (adm.) 14’877 15’438 16’822

Occupancy in % 80.7 86.1 86.0 (average)

CMI Swiss DRG (since - 1.21 1.33 1.1.2012)

Private University Klinik Hirslanden

• Klinik Hirslanden is a cantonally-listed hospital. Additionally, it provides highly-specialised medicine analogous to a university hospital. • By actively enforcing medical and service differentiations between general- and private-insured patients, Klinik Hirslanden continues to focus on the semi-private and private insurance segments.

DR. DANIEL LIEDTKE HOSPITAL MANAGER

KLINIK HIRSLANDEN WITELLIKERSTRASSE 40 CH-8032 ZÜRICH

ANALYST PRESENTATION 18 FEBRUARY 2015

HOSPITAL OVERVIEW KLINIK STEPHANSHORN

ANDREA RÜTSCHE HOSPITAL MANAGER KLINIK STEPHANSHORN KLINIK STEPHANSHORN HISTORY

• 1924: The Menzinger Sisters build a private hospital called Notkerianum (birthplace). Later, the Notkerianum and the hospital Blumenau are merged • 1975: Establishment of Klinik Stephanshorn AG and construction of a new building • 1978: Opening of the new building (today’s main hospital building) • From then on, the Klinik Stephanshorn established as a maternity hospital • 2000 – 2002: Hospital completely refurbished

Hirslanden Analyst Presentation 4 KLINIK STEPHANSHORN HISTORY SINCE HIRSLANDEN

• 10/10 Hirslanden acquires Klinik Stephanshorn

• 11/11 Intermediate Care Unit (IMC)

• 4/13 Obesity Centre

• 7/13 New state-of-the-art operation theatre, called ENDO Alpha

• 8/13 Intensive Care Unit with 6 beds (ICU)

• 9/13 Centre of health with an Emergency Unit and 5 practices

• 10/13 Introduction of a new 3T MRI

• 12/13 As the first private hospital in Switzerland, Stephanshorn certified by the Swiss Cancer Organisation for Breast Cancer as a centre of expertise

Hirslanden Analyst Presentation 5

KLINIK STEPHANSHORN HISTORY AND FUTURE

• 1/14 For the first time ever, more than 500 inpatients a month

• 8/14 Start construction of 12 double rooms (24 beds) / new Emergency Unit, opening 6 April 2015

• 1/15 Introduction of Thorax and Vascular Unit

• 1/15 More than 400 employees

• 4/15 Introduction of new Angiography

Hirslanden Analyst Presentation 6 KLINIK STEPHANSHORN AT A GLANCE

Figures per 31 March 2014 Private 8% •Turn-over of CHF 67 Mio. (+16% PY) •69 doctors affiliated and employed Semi- private •367 employees Basic 25% 67% •100 beds •5 Operating theatres •4 delivery rooms •5,455 inpatients excluding newborns •23,844 patient-days •844 newborns (1% of all newborns in Switzerland) •Length of stay approx. 4.4 days Hirslanden Analyst Presentation 7

MEDICAL SPECIALITIES PER JANUARY 2015

Breast Anaesthesia Obesity (HSM) Surgery Diabetes Surgery

Gastro- Gynaecology Endocrinology Vascular Haematology enterology /Obstetrics

Internal ICU Cardiology Neurosurgery Oncology Medicine

Orthopaedic / Otolaryngology Plastic Surgery Pneumology Radiology traumatology

Visceral Spinal Rheumatology Thorax Surgery Urology Surgery Column Surgery

• 7/24-h Emergency T +41 71 282 74 74 8 KLINIK STEPHANSHORN DEVELOPMENT OF EMERGENCY UNIT

Inpatient Supple • Operational since 09/13 36% mentary • Outpatient transfer to insured General inpatient and insurance 43% Outpatient insured mix are very attractive 64% 57%

Hirslanden Analyst Presentation 9 KLINIK STEPHANSHORN DEVELOPMENT INPATIENTS FY 2011-14

InpatientsInpatients without excl. newborns newborns Newborns

5455

4756 4486 4227

859 825 874 844

FY2011 Transfer Year FY2012 FY2013 FY2014

Hirslanden Analyst Presentation 10 KLINIK STEPHANSHORN DEVELOPMENT EMPLOYEES FY 2011-14

Employees incl. Hospital-Doctors DoctorsAffilliated affiliated doctors

367

305 285 249

61 60 60 60

FY2011 Transfer Year FY2012 FY2013 FY2014

Hirslanden Analyst Presentation 11 KLINIK STEPHANSHORN INVESTMENTS SINCE ACQUISITION

Intermediate Care IMC CHF 2.0m Emergency Unit CHF 7.0m IUC / Operating Theatre / Medical technology Surgery CHF 8.0m Radiology (MR 3T, Uro-Scan, Mammographie, Ultrasound, CHF 5.0m etc.)

Investments < CHF 100,000 since 2010 CHF 3.0m Reconstruction of Sterilisation CHF 2.0m Construction Annex (24 beds) and Emergency Unit CHF 7.5m New Angiography CHF 1.9m

Total to 2014 / 2015 CHF 36.4m Project Study 2020 for new Campus CHF 0.5m

12 KLINIK STEPHANSHORN ENGAGEMENT AND EDUCATION

Klinik Stephanshorn is one of the main employers in St. Gallen

•Currently we educate 38 trainees •Since 2014 we have the permission to educate doctors in emergency and surgical fields

•Graduate Anaesthesia Nurse •Graduate Nurse •Graduate Midwife •Professional Nurse •Administration •Cook •Technician

Hirslanden Analyst Presentation 13 KLINIK STEPHANSHORN FEEDBACK FROM OUR INPATIENTS

How satisfied were you with the service of our nurses

very satisfied 49 31 27

satisfied 9 5 3

more or less 2 2

no 2 Basic Semi-Private Private

Absolutely not satisfied

0% 20% 40% 60% 80% 100%

14 KLINIK STEPHANSHORN FEEDBACK FROM OUR INPATIENTS

Would you recommend our hospital to your family and friends?

Basic Semi-Private Private

No 1 1

Maybe 5 3 2

of course 54 35 27

15 KLINIK STEPHANSHORN INPATIENTS PER DISCIPLINE

1531 1467 FY14 FY13

1149 1073

773 764 722 679

455 477

299 262 164149 58 20 0 0 27 15 33 23 27 19 6 6 22 0

16 KLINIK STEPHANSHORN FUTURE CHALLENGES

• Establishment of Vascular and Thorax Surgery Centre

• Expand new Emergency Unit

• Meet the criteria for highly-specialised medicine (HSM) in Visceral Surgery and Obesity

• Transformation Hirslanden 2020 Strategy

• Introduction of new Hirslanden IT-System (new clinical information system)

17 KLINIK STEPHANSHORN OPPORTUNITIES

• Strategic planning – 2020 'Masterplan'

• Attractive employer within the hospital world

• Introduction of more new disciplines regarding modern state-of-the-art infrastructure such as:

• Interventional Cardiology

• Radiotherapy (Radio-Oncology)

• And others

18 KLINIK STEPHANSHORN VISION OR FUTURE??

«What is more satisfying than having just a vision? To achieve it»

19 THANK YOU